Retention samples [Regulatives / Guidelines]

posted by dshah – India/ United Kingdom, 2021-04-13 19:07 (186 d 04:21 ago) – Posting: # 22308
Views: 1,476

(edited by dshah on 2021-04-13 19:19)

Dear Vinodvasala!

Please search in forum for previous discussions  ,  ,  . In general as per Compliance Policy for the Quantity of Bioavailability and Bioequivalence Samples Retained Under 21 CFR 320.38(c)- 30 units for Drug Products Manufactured in Single-Dose Units or 3 units for Drug Products Manufactured in Multi-Dose Units for US regulatory and 300 units for 5X testing (safer approach).
Regards,
Dshah

Complete thread:

Activity
 Admin contact
21,729 posts in 4,543 threads, 1,543 registered users;
online 13 (0 registered, 13 guests [including 4 identified bots]).
Forum time: Saturday 23:29 CEST (Europe/Vienna)

If you want to converse with me,
define your terms.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5